Investments

Study Group is the leading provider of international education in the UK and Europe, Australia, New Zealand and North America. Each year, Study Group supports over 30,000 students from around 142 countries on campuses spread across three continents. Study Group prepares international students, who wish to enter leading English-speaking universities, through educational courses that provide them with the academic, language and learning skills needed to succeed. Study Group is a market leader in the UK and in Australia, and partners with numerous prestigious universities across the globe.

Founded in 1952, Revima is an independent leader in the maintenance, repair and overhaul of commercial aircraft. The group is well-known for its expertise in the maintenance of auxiliary power units (APU) and landing gear for regional, medium and long-haul aircraft. Revima, which has c.750 employees, achieved revenues of more than €280M in 2018.

Founded in Rimini in 1974, Celli S.p.A is a leading Italian beverage solutions company. Celli specializes in the design, manufacturing, testing and installation of innovative beverage dispensing solutions for breweries (including Heineken, Carlsberg, Asahi, Molson Coors, Budweiser) and soft drinks companies (including Coca-Cola and Pepsi). The Group is also involved in the manufacturing of water dispensers, developing solutions that are more sustainable than bottled beverage consumption.

Inula Group was created following the merger of Pranarôm and HerbalGem, two pioneering laboratories specialized in natural therapies, founded in 1985 and 1986 respectively. Inula is a key player in the herbal remedies market, specializing in fast growing sub-sectors such as aromatherapy, gemmotherapy and Bach flowers, through three brands: Pranarôm, HerbalGem and Biofloral. Thanks to its strong scientific approach and the quality of its products, the Group has experienced significant growth over the past years and is now present in more than 25 countries, with leading positions in France, Belgium, Spain, Italy and the USA.

Neopharmed Gentili represents the spin-off of the primary care business of Mediolanum Farmaceutici Group and is a leading pharmaceutical company in the Italian market focused on branded prescription drugs in cardiovascular, neurology and allergo-respiratory therapeutic areas, with a portfolio of off-patent and mostly proprietary products. Its flexible and asset-light business model makes Neopharmed Gentili an attractive commercial platform with a proprietary, reliable, and specialized sales force of over 400 pharma representatives.

Created in 1932 and headquartered in Dax (France), DRT is a global leading producer of ingredients derived from plant-based chemistry, mainly from pine trees. With a turnover estimated at €500m in 2017, DRT is a truly international company with more than 80% of its business made outside of France, of which around 25% in the Americas and more than 10% in Asia. The group employs close to 1,300 people and is operating through a global footprint with four production sites located in France, two in the USA, three in India and one in China.